Clinical Trial

Creation of a Clinical Database on Primary Nervous System Tumors

Study acronym: BDD-NO
Recruiting
View on ClinicalTrials.gov →
Summary
the creation of a clinical database including data for all PCNST patients is of high interest. This database will allow us to develop clinical studies on: * The clinical, radiological and biological presentation of tumors, the impact of oncological treatments and the evaluation of survival for the different subtypes of Primary central nervous system tumors (PCNST). This is particularly important for rare histological subtypes of PCNST for which the current knowledge is scarce; * Clinical, radiological and biological factors predictive of tumor response to treatments; * Prognostic factors.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2020-08-14; most recent amendment 2025-02-11.
Trial Details
NCT Number NCT04516720
Lead Sponsor Institut du Cancer de Montpellier - Val d'Aurelle
Conditions Nervous System Tumor
Enrollment 1,700 participants
Start Date 2018-01-01
Primary Completion 2035-01 (estimated)
Study Completion 2039-01 (estimated)
Updated on ClinicalTrials.gov 2025-02-12